viewLexaria Bioscience Corp.

Hill Street Beverage CEO to present investment case at the Extraordinary Future Conference in Vancouver

Hill Street produces alcohol-free beer and wine, and will sell cannabis-infused drinks when edibles become legal in Canada in October

Lexaria Bioscience Corp - Hill Street Beverage CEO to present investment case at the Extraordinary Future Conference in Vancouver
Hill Street has acquired two global semi-exclusive licenses to utilize Lexaria Bioscience’s DehydraTECH THC and CBD beverage infusion technologies for 10 years

Hill Street Beverage Company Inc (TSXV:BEER) (OTCMKTS:HSEEF) said Thursday that CEO Terry Donnelly will make the company’s investment case at the two-day Extraordinary Future Conference in Vancouver.  

In a statement, the company said Donnelly will present Hill Street's investment thesis at 10:20 am Pacific Time on September 22, at Workshop Stage 1 at the Vancouver Convention Centre West.

Donnelly will also participate in the “Technology Behind Infused Cannabis Beverages” panel discussion at 4:30 pm Pacific Time on the main stage on the same day. Investors can also learn more about Hill Street's alcohol-free beer, wine, and adult-format beverages and its future cannabis-infused beverages by dropping in at booth No 302.

READ: Hill Street makes big bet on cannabis-infused drinks

"Hill Street has established a portfolio of award-winning, non-alcoholic beer and wine brands that will serve as perfect platforms to deliver our cannabis infused beverages to the Canadian market following the legalization of edibles in October 2019," said Donnelly in a statement.

“Our pending acquisition of OneLeaf Holdings will not only give us a world class, 48,200 square foot facility built to EU GMP standards but also a catalogue of over 700 distinct cannabis cultivars and the talent that created them,” he added.

Hill Street is gearing up to produce its own line of cannabis-infused beverages, and has acquired two global semi-exclusive licenses to utilize Lexaria Bioscience Corp’s (CSE:LXX) (OTCMKTS:LXRP) DehydraTECH THC beverage infusion technology, and to use the DehydraTECH CBD infusion technology around the world for 10 years. This expands a 2018 license award to Hill Street to use DehydraTECH for THC beverages in Canada only,

“Our joint manufacturing partnership with Lexaria allows us to produce DehydraTECH commercial products, including both processed THC and CBD powders in the form of compressed tablets, capsules, or sachets for new consumer products for sale in Canada and for export where permitted,” said Donnelly.

Hill Street's award-winning products include Hill Street Craft Brewed Lager, designated draft alcohol-free beer, Vin(Zero) wines, and Vintense wines.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter: @UttaraProactive 

Quick facts: Lexaria Bioscience Corp.

Price: 0.46 CAD

Market: CSE
Market Cap: $41.21 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lexaria Bioscience Corp. named herein, including the promotion by the Company of Lexaria Bioscience Corp. in any Content on the Site, the...



Lexaria Bio Science and partner Altria complete Phase One of the development...

Lexaria BioScience (OTCQX: LXRP- CSE: LXX) CEO Chris Bunka joined Steve Darling from Proactive Vancouver with news the company has seen their Phase One research and development program of oral forms of nicotine delivery finish with Altria Ventures. Bunka says everything went as planned and...

3 weeks, 5 days ago

2 min read